new eye drop for glaucoma, Alphagan (brimonidine)
October 1996
This month Allergan is launching a new eye drop for glaucoma, Alphagan (brimonidine).
Alphagan is a selective alpha-2 agonist. It lowers intraocular pressure by reducing fluid production in the eye...AND increasing its outflow.
It'll be used as an alternative for patients who can't tolerate or don't respond to topical beta-blockers (Timoptic, etc).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote